Últimas noticias sobre Sagimet Biosciences (NASDAQ:SGMT) Bolsa

Sagimet Biosciences

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences Inc

Walmart (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>), the consumer defensive giant, has been on an impressive run in 2024, surging over 51% year-to-date (YTD) and outperforming both its sector and the broader market. Recently, analysts at Citi upgraded their stance on the stock, becoming even more bullish after already being long-time supporters. They raised their price target on Walmart, citing significant growth ahead, and believe the company is well-positioned to continue dominating the retail space, gaining more market share.
Despite Walmart&#39;s nearly 50% rally over the past year, Citi&#39;s recent upgrade begs the question: Is it still a good time to buy?
<h2>Citi Analysts Turn More Bullish on Walmart</h2>
According to Citi&#39;s latest research note, Walmart is &quot;well-positioned&quot; for future growth despite potential consumer uncertainty. Citi raised its price target to $98 from $75, highlighting Walmart&#39;s substantial market share gains, especially in its grocery segment and solid e-commerce presence. Analysts noted that Walmart has been capitalizing on its strength in food and grocery by offering value in an inflationary environment, all while enhancing convenience with services like curbside pickup.
Beyond groceries, Citi points out that Walmart is in the early stages of building out several high-margin growth businesses, including marketplace operations, fulfillment services, data services, and advertising. According to the analysts, these initiatives will help Walmart maintain its competitive edge for years to come.
Citi&#39;s bullish commentary comes just over a month after Walmart posted its second-quarter earnings, where the retailer posted solid results. Walmart exceeded expectations with adjusted earnings per share (EPS) of $0.67, beating the $0.65 consensus, while revenue hit $169.3 billion, up 4.7% year-over-year. CEO Doug McMillon highlighted that each segment of the business is growing, from in-store and club sales to e-commerce. McMillon also emphasized that newer ventures like advertising and membership services are adding to the company&#39;s diverse profit streams.
For the upcoming quarter, Walmart expects earnings per share to fall between $0.51 and $0.52, slightly below the consensus of $0.54. However, the company raised its full-year forecast, projecting EPS of $2.35 to $2.43, up from the previous range of $2.23 to $2.37.
<h2>Time to Buy Walmart?</h2>
From a technical standpoint, Walmart&#39;s momentum is strong, with the stock trading just over 2% away from its 52-week high and above all key moving averages. However, given the recent surge, it may be wise for investors to wait for a pullback, possibly closer to its rising 200-day moving average of around $75. Walmart&#39;s current P/E ratio of 41.45 and forward P/E of 29.32 are elevated, further suggesting that waiting for a pullback could offer a more favorable entry point.
Still, Walmart&#39;s longer-term growth story remains compelling. The retailer continues to raise its guidance, gain market share, and diversify into higher-margin businesses, making it a potential top pick for capital appreciation and income generation through its dividend. Even with the stock&#39;s significant rally, its combination of strong fundamentals and future growth potential makes it a solid choice for long-term investors.
While short-term caution might be advisable, Walmart&#39;s overall bullish outlook and dominance in key segments make it a stock to watch closely for any potential buying opportunities.&nbsp;
The article &quot;<a href="https://www.marketbeat.com/originals/citi-analysts-turn-more-bullish-on-walmart-stock-time-to-buy/">Citi Analysts Turn More Bullish on Walmart Stock: Time to Buy?</a>&quot; first appeared on MarketBeat.

Earnings

Earnings Beats

Large Cap

News

Guidance

Dividends

Price Target

Technicals

Retail Sales

Markets

Analyst Ratings

Trading Ideas

Citi Analysts Turn More Bullish on Walmart Stock: Time to Buy?

Retirement looks different for everyone, but what does it take to be in the top 10% of wealthy retirees?&nbsp;
It's not about flashy yachts or endless vacations. The top tier is defined by solid financial planning, diverse income streams and a clear understanding of stretching wealth beyond Social Security checks.&nbsp;
If you're curious about where you stand, here's how to tell if you're <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">among the top retirees of 2024</a>.
Don't Miss:
<ul>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
</ul>
The Top 10% Net Worth: What's the Magic Number?
To crack the top 10% of retirees, your net worth needs to hit around $1.9 million, according to Federal Reserve Board survey data. For those aged 65-74, that figure jumps to about $2.63 million; for retirees 75 and older, it climbs even higher to $2.86 million. This sharply contrasts the average retiree, whose net worth is much lower – closer to $280,000 on average. If you've crossed that $2 million line, you're likely looking at a very different retirement experience from the average.
Trending: One trailblazing female with an expertise in renewable energy built a company that's bringing the EV revolution to disadvantaged communities —<a href="https://www.benzinga.com/money/dunamis-1"> here&#8217;s how you can invest at just $500</a>
Top Retiree Earnings – Without a Salary
Here's where things get interesting. Wealthy retirees aren't just sitting on a pile of money. They've built multiple streams of income that continue to flow well into retirement.&nbsp;
While Social Security might pay a max of $58,476 annually (if you're lucky), top retirees are pulling in much more – without even breaking a sweat. Their income comes from investments, rental properties, pensions and sometimes businesses they've built or invested in.
See Also: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
The average retiree earns around $75,000 annually, but the top 10% bring in significantly more. For those aged 65 to 69, the top 10% have an annual income of $200,000.
They earn income from a combination of dividends, rental properties and strategic portfolios, which allows them to live comfortably without draining their principal savings.
See Also: <a href="https://www.benzinga.com/money/irs-finalizes-10-year-rule-adv">IRS Finalizes 10-Year Rule For Retirement Withdrawals, Making Things &#8216;Even More Insanely Complicated&#8217;</a>
Portfolio Strategy: What Do Top Retirees Do Differently?
Wealthy retirees approach investing with a long-term mindset. It's not about playing it safe; it's about balance. A typical portfolio for someone in the top 10% might hold around 60% stocks, 35% bonds and just 5% cash or cash-like investments. They're still looking for growth even in retirement, rather than shifting entirely to conservative investments.
This keeps their wealth growing while also providing income. They may dial down the risk as they age, but you won't see these retirees parking all their money in low-yield savings accounts.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
How Location Plays Into Wealth Perception
One factor that often goes overlooked in retirement is where you live. Retirees in certain cities will see their income stretch further. While retirees in high-income areas may bring in around $90,000 a year, someone in a lower-cost city might live just as well with less. For top 10% retirees, maintaining a high quality of life often comes from flexibility in where they choose to retire.
Retiring in the top 10% isn't just about luck – it results from smart planning, diverse income sources and a solid investment strategy. Understanding what it takes can help you aim higher if you&#8217;re not there yet. It's always a good idea to <a href="https://www.benzinga.com/money/charlie-munger-100k">consult a financial advisor</a> to ensure you&#8217;re on the right track.&nbsp;
Read Next:
<ul>
<li>Are you richer than most people you know?<a href="https://www.benzinga.com/money/are-you-richer-than-most-people"> Here&#8217;s the net worth you need at every age to be above average.</a></li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>

Personal Finance

Are You A 'Rich' Retiree? Here's The Net Worth And Income You Need To Be In The Top 10%

Wells Fargo analyst Timur Braziler maintains Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) with a Equal-Weight and raises the price target from $26 to $28.

COLB

Wells Fargo Maintains Equal-Weight on Columbia Banking System, Raises Price Target to $28

<a href="https://www.bloomberg.com/news/articles/2024-10-01/apple-readies-iphone-se-4-upgraded-ipad-air-for-early-2025?srnd=undefined">https://www.bloomberg.com/news/articles/2024-10-01/apple-readies-iphone-se-4-upgraded-ipad-air-for-early-2025?srnd=undefined</a>
&nbsp;
Apple Inc., fresh off the release of the iPhone 16, is preparing to announce a new low-end phone early next year alongside upgraded iPads.&nbsp;

AAPL

'Apple Readies New iPhone SE, Upgraded iPad Air for Early Next Year' - Bloomberg

Financial giants have made a conspicuous bearish move on Valero Energy. Our analysis of options history for Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) revealed 8 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $75,500, and 6 were calls, valued at $204,499.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $110.0 to $150.0 for Valero Energy over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Valero Energy's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Valero Energy's whale trades within a strike price range from $110.0 to $150.0 in the last 30 days. 
<h3>Valero Energy Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727811069_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/04/24</td>
<td>$2.91</td>
<td>$1.0</td>
<td>$1.0</td>
<td>$138.00</td>
<td>$45.5K</td>
<td>108</td>
<td style="text-align: right;">645</td>
</tr>
<tr>
<td>VLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$4.35</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$137.00</td>
<td>$43.0K</td>
<td>159</td>
<td style="text-align: right;">73</td>
</tr>
<tr>
<td>VLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$137.00</td>
<td>$37.0K</td>
<td>171</td>
<td style="text-align: right;">243</td>
</tr>
<tr>
<td>VLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.75</td>
<td>$3.6</td>
<td>$3.62</td>
<td>$150.00</td>
<td>$36.2K</td>
<td>30.3K</td>
<td style="text-align: right;">115</td>
</tr>
<tr>
<td>VLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.25</td>
<td>$135.00</td>
<td>$32.5K</td>
<td>1.3K</td>
<td style="text-align: right;">107</td>
</tr>
</tbody>
</table>

<h3>About Valero Energy</h3>
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which has the capacity to produce 1.2 billion gallons per year of renewable diesel.
In light of the recent options history for Valero Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Valero Energy</h3>
<ul>
<li>With a volume of 2,116,758, the price of VLO is up 1.61% at $137.21. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 23 days.</li>
</ul>
<h3>What Analysts Are Saying About Valero Energy</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $149.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Neutral, setting a price target of $123. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Valero Energy, maintaining a target price of $172. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Valero Energy with a target price of $171. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Sell rating for Valero Energy, targeting a price of $131. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Valero Energy options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Looking At Valero Energy's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on Apple. Our analysis of options history for Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) revealed 187 unusual trades.
Delving into the details, we found 48% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 96 were puts, with a value of $5,898,254, and 91 were calls, valued at $5,839,083.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $115.0 to $250.0 for Apple during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Apple's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Apple's whale activity within a strike price range from $115.0 to $250.0 in the last 30 days. 
<h3>Apple Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727811064_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$2.38</td>
<td>$2.33</td>
<td>$2.38</td>
<td>$225.00</td>
<td>$177.5K</td>
<td>5.8K</td>
<td>28.7K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.95</td>
<td>$12.9</td>
<td>$12.9</td>
<td>$230.00</td>
<td>$149.6K</td>
<td>1.4K</td>
<td>950</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$4.65</td>
<td>$4.55</td>
<td>$4.6</td>
<td>$225.00</td>
<td>$135.2K</td>
<td>24.1K</td>
<td>6.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/04/24</td>
<td>$2.62</td>
<td>$2.62</td>
<td>$2.62</td>
<td>$225.00</td>
<td>$131.0K</td>
<td>16.5K</td>
<td>49.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.5</td>
<td>$6.4</td>
<td>$6.42</td>
<td>$240.00</td>
<td>$128.4K</td>
<td>35.3K</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h3>About Apple</h3>
Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality. The firm designs its own software and semiconductors while working with subcontractors like Foxconn and TSMC to build its products and chips. Slightly less than half of Apple's sales come directly through its flagship stores, with a majority of sales coming indirectly through partnerships and distribution.
After a thorough review of the options trading surrounding Apple, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Apple</h3>
<ul>
<li>Currently trading with a volume of 42,737,800, the AAPL's price is down by -3.1%, now at $225.77. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 30 days.</li>
</ul>
<h3>What Analysts Are Saying About Apple</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $247.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Neutral rating on Apple, maintaining a target price of $236. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $260. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Apple, targeting a price of $256. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $260. 
&#x2A; An analyst from New Street Research downgraded its action to Neutral with a price target of $225. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Apple options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Decoding Apple's Options Activity: What's the Big Picture?

Investors with a lot of money to spend have taken a bearish stance on Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TTD, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Trade Desk.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 62%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $129,479, and 4 are calls, for a total amount of $139,365.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $82.5 to $120.0 for Trade Desk over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Trade Desk stands at 465.71, with a total volume reaching 699.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Trade Desk, situated within the strike price corridor from $82.5 to $120.0, throughout the last 30 days.
<h3>Trade Desk Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727811058_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.6</td>
<td>$13.2</td>
<td>$13.2</td>
<td>$120.00</td>
<td>$55.4K</td>
<td>329</td>
<td style="text-align: right;">101</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$8.6</td>
<td>$8.45</td>
<td>$8.53</td>
<td>$110.00</td>
<td>$38.3K</td>
<td>613</td>
<td style="text-align: right;">118</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$7.45</td>
<td>$7.3</td>
<td>$7.45</td>
<td>$85.00</td>
<td>$34.2K</td>
<td>15</td>
<td style="text-align: right;">47</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.5</td>
<td>$13.25</td>
<td>$13.25</td>
<td>$120.00</td>
<td>$33.1K</td>
<td>329</td>
<td style="text-align: right;">35</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.86</td>
<td>$1.84</td>
<td>$1.84</td>
<td>$105.00</td>
<td>$30.3K</td>
<td>1.0K</td>
<td style="text-align: right;">373</td>
</tr>
</tbody>
</table>

<h3>About Trade Desk</h3>
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on different devices like computers, smartphones, and connected TVs. It utilizes data to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry. The firm generates its revenue from fees based on a percentage of what its clients spend on advertising.
<h3>Where Is Trade Desk Standing Right Now?</h3>
<ul>
<li>With a volume of 1,375,040, the price of TTD is down -0.34% at $109.28. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 37 days.</li>
</ul>
<h3>What The Experts Say On Trade Desk</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $115.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $110. 
&#x2A; An analyst from B of A Securities has revised its rating downward to Buy, adjusting the price target to $135. 
&#x2A; An analyst from MoffettNathanson downgraded its action to Neutral with a price target of $100. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $115. 
&#x2A; Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Trade Desk, targeting a price of $115. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Trade Desk options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Trade Desk Options Trading: A Deep Dive into Market Sentiment

WIIM

PRZO

PanZero Technologies shares are trading higher after the company announced it secured a new order for its advanced counter-drone system from global defense and intelligence OEM amid growing demand for C-UAS solutions.

Wells Fargo analyst Timur Braziler maintains East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) with a Overweight and raises the price target from $95 to $97.

EWBC

Wells Fargo Maintains Overweight on East West Bancorp, Raises Price Target to $97

Macro Notification

General

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Israeli Military Following Iran's Attack Says 'We Will Choose When To Prove Our Precise And Surprising Attack Capabilities'

Wells Fargo analyst Timur Braziler maintains First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) with a Equal-Weight and raises the price target from $20 to $22.

Wells Fargo Maintains Equal-Weight on First BanCorp, Raises Price Target to $22

Semiconductor chip stocks led by Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) noted investor selloff since Friday after gaining from Micron Technology, Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) upbeat quarterly print and U.S. Fed rate cut to boost demand.
Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Qualcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), Texas Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), Micron, Analog Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>), Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), Marvell Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) are trading lower Tuesday. Semiconductor ETFs VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) and iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) are down over 3%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/10/41124391/qualcomm-partners-with-stmicroelectronics-to-boost-ai-powered-iot-connectivity" rel="noreferrer noopener">Qualcomm Partners With STMicroelectronics To Boost AI-Powered IoT Connectivity</a>
The street remains jittery over <a target="_blank" href="https://www.benzinga.com/news/24/10/41119735/nvidia-faces-new-competition-cerebras-files-for-ipo-huawei-pushes-ai-chips" rel="noreferrer noopener">artificial intelligence prospects</a> as analysts flagged Nvidia&#8217;s dependence on four customers, which are also developing in-house chips, and its delays in product releases.
Though China urges its companies to adopt domestic AI chipmakers, National Science and Technology Council (NSTC) Minister Wu Cheng-wen said China lags behind Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) <a href="https://www.benzinga.com/government/24/10/41114632/taiwan-semiconductors-2-nm-breakthrough-puts-taiwan-a-decade-ahead-of-chinas-semiconductor-industry" target="_blank" rel="noreferrer noopener">advanced technology semiconductor manufacturing</a> by at least a decade. Taiwan Semiconductor is a crucial supplier for Nvidia and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
The U.S. Chips Act played a crucial role in helping America develop its semiconductor base by offering <a target="_blank" href="https://www.benzinga.com/government/24/09/41007184/taiwan-semi-secures-7-5b-boost-for-arizona-expansion-aims-for-advanced-chip-production-report" rel="noreferrer noopener">subsidies to chipmakers</a> to boost artificial intelligence chip production in the country.
The semiconductor sector could see another tailwind if the Biden administration inks a bill to fastrack the specific semiconductor manufacturing projects that receive subsidies through the Chips Act by diluting the federal environmental scrutinies.
The legislation would exempt qualifying chip projects from reviews under the National Environmental Policy Act, the New York Times <a href="https://www.nytimes.com/2024/10/01/us/politics/biden-semiconductor-environmental-review.html" target="_blank" rel="noreferrer noopener">reports</a>.
Struggling chipmaker Intel recently got a boost from <a href="https://www.benzinga.com/news/24/09/40897994/whats-going-on-with-intel-stock-on-tuesday" target="_blank" rel="noreferrer noopener">$3 billion in direct funding</a> under the Chips Act in addition to the $8.5 billion in grants and $11 billion in loans that the company previously won under the act.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41124123/micron-set-for-profit-surge-with-high-margin-products-and-ai-driven-market-expansio" target="_blank" rel="noreferrer noopener">Micron Set for Profit Surge with High-Margin Products and AI-Driven Market Expansion, Analyst Says</a></li>
</ul>
Photo via Shutterstock

Government

Regulations

Tech

Media

AVGO

INTC

MRVL

NVDA

QCOM

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Despite Nvidia Selloff, Biden's Law and Taiwan Semi's Advantage Offer Growth Potential

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock&#39;s price, do they really matter?
Let&#39;s take a look at what these Wall Street heavyweights have to say about Archrock Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aroc#NYSE">AROC</a>) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
Archrock Inc. currently has an average brokerage recommendation of 1.33, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by six brokerage firms. An ABR of 1.33 approximates between Strong Buy and Buy.
Of the six recommendations that derive the current ABR, four are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 66.7% and 33.3% of all recommendations.
<h2>Brokerage Recommendation Trends for AROC</h2>
<img alt="Broker Rating Breakdown Chart for AROC" class="chart" src="https://staticx-tuner.zacks.com/images/yesopchart/brokerage_bar/AROC_10012024.png" style="width:100%" title="" /> 
The ABR suggests buying Archrock Inc., but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.
Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five &quot;Strong Buy&quot; recommendations for every &quot;Strong Sell&quot; recommendation.
In other words, their interests aren&#39;t always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock&#39;s price movement.
With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock&#39;s near -term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.
<h2>Zacks Rank Should Not Be Confused With ABR</h2>
Although both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.
Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company&#39;s changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
<h2>Is AROC a Good Investment?</h2>
In terms of earnings estimate revisions for Archrock Inc., the Zacks Consensus Estimate for the current year has increased 3.4% over the past month to $1.04.
Analysts&#39; growing optimism over the company&#39;s earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Archrock Inc.
Therefore, the Buy-equivalent ABR for Archrock Inc. may serve as a useful guide for investors.
<a href="https://www.zacks.com/stock/news/2343974/wall-street-analysts-think-archrock-inc-aroc-is-a-good-investment-is-it?cid=CS-BENZ-FT-fundamental_analysis|average_broker_rating-2343974">To read this article on Zacks.com click here.</a>

Mid Cap

AROC

Wall Street Analysts Think Archrock Inc. Is a Good Investment: Is It?

LBPH

Shares Of Longboard Pharmaceuticals See Volume; Hearing Traders Circulating Mentions Of Co. On M&A Blog

BCTX

BriaCell Therapeutics shares are trading lower after the company announced a $5.13 million offering of shares and warrants priced at $0.975 per unit.

Wells Fargo analyst Timur Braziler maintains First Hawaiian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>) with a Underweight and lowers the price target from $22 to $20.

Wells Fargo Maintains Underweight on First Hawaiian, Lowers Price Target to $20

Wells Fargo analyst Timur Braziler maintains Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) with a Equal-Weight and raises the price target from $85 to $92.

Wells Fargo Maintains Equal-Weight on Western Alliance, Raises Price Target to $92

Interest rates determine the risk and reward perceptions of virtually all asset classes in the financial market. The benchmark for return is&mdash;and has always been&mdash;the United States ten-year treasury bond yield, so when bond yields are high, investors tend to avoid higher-risk assets like stocks, as the risk is not worth it compared to bond yields.
Now that the Federal Reserve (the Fed) has lowered interest rates by the most since 2007, investors may think that lower returns could be ahead, especially now that the S&amp;P 500 has priced in most&mdash;if not all&mdash;of the potential effects these interest rate cuts have on the economy. Understanding that new money will shift into different market areas is key. Still, it all begins with knowing what interest rates will do in the coming quarters.
Sectors that typically have higher debts on their balance sheets are poised to benefit from lower interest rates. Lower interest expenses on that debt would drive up net income and earnings per share (EPS). For this reason, investors can find higher returns in sectors like consumer discretionary and the real estate sector.
<h2>Top Consumer Discretionary Stocks Poised for Higher Growth Ahead</h2>
This is one sector that could benefit from a double tailwind as interest rates work their way through the economy. Still, not all consumer discretionary stocks are made equal. This is going to be the case, especially for those with a smaller market capitalization and higher debt.
<h3>Analysts Expect Abercrombie&#39;s EPS to Jump 14.5% by 2025</h3>
Fitting this list, investors can see stocks like Abercrombie &amp; Fitch Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anf#NYSE">ANF</a>), with its $7.3 billion market capitalization today, carrying over 73% debt to equity on its balance sheet. This makes the company a prime target for an EPS expansion name, as lower interest rates help both consumer trends and lower interest expenses.
Wall Street knows this is the case, as analysts at Jefferies Financial Group see up to $220 as a price target for the company, calling for a net upside of 53.3% from where the stock trades today. More than that, Wall Street analysts expect to see EPS of $2.86 for the end of 2025, a jump of 14.5% from today&#39;s EPS of $2.5 in Abercrombie &amp; Fitch.
This growth in EPS and the higher valuation are driven by both the company&#39;s small size and the potential earnings expansion that can come from lowering interest expenses to push EPS higher to a point where current forecasts might be on the conservative side.
<h3>Chewy&#39;s Debt and Size Make It a Prime Target for Future Gains</h3>
Another name that is worth mentioning for a potential buy in this trend is Chewy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) as a part of the consumer discretionary space with a healthy mix of consumer staples in the way that pet owners will always have room in their budgets to take care of their pets&#39; needs.
Because the company is only $12.6 billion in size and carries over 100% in debt compared to equity, it makes for a nearly perfect buy target in the coming quarters. This is why analysts at Piper Sandler see a price target on the stock of up to $35 a share, calling for a net upside potential of 16.3% from where it trades today.
More than that, bearish traders decided to trim their views on Chewy stock, as the short interest has declined by 2% over the past month alone to show capitulation from the bearish side of the market and opening room for bulls to take their places instead.
Among these bulls were Truist Financial and B. Riley Wealth Advisors, who boosted their holdings in Chewy stock by 39.3% and 74% as of August 2024. This would bring their net investments up to $2.5 million and $565,000 today.
<h2>Real Estate Stocks Poised for Growth Ahead of the Market</h2>
<h3>Healthpeak&#39;s Dividend and Growth Potential Make It a Standout REIT</h3>
Real estate stocks fit this same category. Because they need to acquire property and boost rental income, stocks like&nbsp;Healthpeak Properties Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/doc#NYSE">DOC</a>) shine. This $15.9 billion real estate investment trust (REIT) operates in the healthcare sector, an underrated growth source in the U.S. economy.
Wall Street analysts know that lower interest rates can help this company acquire more property and boost its bottom-line earnings, so Evercore decided to raise its price target to $26 a share for Healthpeak Properties. To prove these targets right, the stock must rally by as much as 15% from where it trades today.
Wall Street&#39;s earnings per share (EPS) forecasts are set at $0.44 a share for the next 12 months, up from today&#39;s $0.21 a share for a net 109.5% growth rate. This comes on top of one of the main benefits of investing in REITs: the dividend payout.
Healthpeak Properties offers a $1.2 payout for an annualized dividend yield of up to 5.3% to beat inflation and cushion any volatility that lower rates might bring into the market.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/lower-rates-higher-returns-key-stocks-to-watch-now/">Lower Rates, Higher Returns: Key Stocks to Watch Now</a>&quot; first appeared on MarketBeat.

REIT

Real Estate

CHWY

Lower Rates, Higher Returns: Key Stocks to Watch Now

Phoenix Motor Says Determined The "Proterra Financial Statements" Is Incorrect

Cryptocurrency markets are trading lower amid escalating tensions in the Middle East.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$61,888.86&nbsp;&nbsp;</td>
<td>&nbsp;-2.5%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,498.87&nbsp;&nbsp;</td>
<td>&nbsp;-3.5%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$147.33&nbsp;&nbsp;</td>
<td>&nbsp;-5%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1074&nbsp;&nbsp;</td>
<td>&nbsp;-9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001633</td>
<td>-8.3%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increased by around 99% and daily active addresses rose by 7.1%. Transactions greater than $100,000 are up from 5,655 to  9,193 in a single day. Exchanges netflows are down by 1,521.2%.</li>
<li>Coinglass data reports 159,405 traders were liquidated in the past 24 hours for $482.24 million, with crypto long liquidations of $361.8 million at the highest since Aug. 5. Bitcoin long liquidations of $90.7 million are at the highest level since Aug. 5.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41125099/ripple-receives-dubai-approval-for-blockchain-payment-services">Ripple Receives Dubai Approval For Blockchain Payment Services</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41122002/playbux-ceo-envisions-web3-future-where-crypto-is-earned-via-gaming-shopping">Playbux CEO Envisions Web3 Future Where Crypto Is Earned Via Gaming, Shopping</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41120425/arthur-hayes-cites-money-printing-as-key-factor-for-bitcoin-becoming-the-best-performing-a">Arthur Hayes Cites &#8216;Money Printing&#8217; As Key Factor For Bitcoin Becoming The &#8216;Best Performing Asset&#8217; In History</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41111755/robinhood-markets-launches-crypto-transfers-in-europe-enabling-bitcoin-ethereum-and-solana">Robinhood Markets Launches Crypto Transfers In Europe, Enabling Bitcoin, Ethereum, And Solana Transactions With 1% Deposit Match For A Limited Time</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41114110/the-dollar-is-weakening-heres-why-that-could-be-good-for-bitcoin-10x-research">The Dollar Is Weakening—Here&#8217;s Why That Could Be Good For Bitcoin: 10x Research</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41109127/asias-microstrategy-metaplanet-grabs-107-additional-bitcoins-to-boost-portfolio-by-nearly-">&#8216;Asia&#8217;s MicroStrategy&#8217; Metaplanet Boosts Portfolio With Fresh Acquisition Of 107 Bitcoins Worth Nearly $7M</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Arweave (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AR</a>)</td>
<td>&nbsp;$19.67</td>
<td>&nbsp;-15.7%</td>
</tr>
<tr>
<td>Gala (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">GALA</a>)</td>
<td>&nbsp;$0.02032&nbsp;&nbsp;</td>
<td>&nbsp;-13.9%</td>
</tr>
<tr>
<td>Notcoin (CRYPTO: NOT)</td>
<td>&nbsp;$0.007543</td>
<td>&nbsp;-13.3%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices retreating lower to $61,000, crypto trader Cold Blooded Shiller stated that even anything down into the green box represents opportunity for some of the best risk-reward long exposure to six-figure Bitcoin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Do not forget, in the midset of the red candles that even anything down into the green box represents opportunity for some of the best risk-reward long exposure to 6-figure <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>. <a href="https://t.co/AcMwgbZrFp">https://t.co/AcMwgbZrFp</a> <a href="https://t.co/IKf4GwQGB1">pic.twitter.com/IKf4GwQGB1</a>
&mdash; Cold Blooded Shiller (@ColdBloodShill) <a href="https://twitter.com/ColdBloodShill/status/1841170691556597971?ref_src=twsrc%5Etfw">October 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1841159390428115314">detailed</a> that Bitcoin has made a higher low and a higher high. He suggests the trend may have shifted from bearish to bullish.
Crypto trader Jelle compared the current Bitcoin price movement to its historical trends. He predicts new legs to start in October, "breaking out in the 2nd or 3rd week of the month."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">In the past bull-years, <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> has taken the summer to recharge, preparing for the next leg higher. All of those new legs higher started in October &#8211; breaking out in the 2nd or 3rd week of the month. I don&#39;t think this year is different. Final shakeout before new highs. <a href="https://t.co/CXEHhebEMU">pic.twitter.com/CXEHhebEMU</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1841153285580878310?ref_src=twsrc%5Etfw">October 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another crypto trader, IncomeSharks, <a href="https://x.com/IncomeSharks/status/1841173131572232524">believes</a> that if Bitcoin is able to re-test, "we continue back up."
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41119368/what-does-technical-analysis-say-about-bitcoin">What Does Technical Analysis Say About Bitcoin?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$GALA

$SHIB

$SOL

Bitcoin, Ethereum, Dogecoin Begin 'Uptober' Deep In The Red, But Traders See This As The 'Final Shakeout'

Sagimet Biosciences' Denifanstat Remains A Strong Buy Despite Eli Lilly's Tirzepatide

An update from Sagimet Biosciences, Inc. Class A (SGMT) is now available. Sagimet Biosciences Inc. has expanded its Board of Directors, appointing ...

Sagimet Biosciences Expands Board with Two Key Appointments

89bio: Bullish In Light Of Further MOA Being Established By Peer

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sagimet Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgmt-stock-quote/">SGMT</a>) just reported results for the second quarter of 2024.<ul><li>Sagimet Biosciences reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -33 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sgmt-stock-earnings-sagimet-biosciences-for-q2-of-2024/">SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report), retaining the price targe...

Buy Rating Backed by Positive Phase 2b Results and Potential for MASH Backbone Therapy

Sagimet Biosciences GAAP EPS of -$0.25

Sagimet Biosciences files $300M mixed securities shelf

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Liquidia Technologies (LQDA – Research Report) and S...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Sagimet Biosciences, Inc. Class A (SGMT)

Sagimet soars on FDA breakthrough therapy designation for its liver disease treatment

Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report). The ass...

Buy Rating Justified: Sagimet Biosciences' Denifanstat Poised to Transform NASH Treatment Landscape

AKRO

ASCLF

ETNB

LQDA

MDGL

SGMT

VKTX

Press Releases

Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Health Care

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024

Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat

Management

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit

Sagimet Biosciences to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference and Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH

BRNS

RCUS

SNDX

TRVN

ZURA

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

AlloVir

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

BioAtla

Benitec Biopharma

BeyondSpring

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Cibus

Chimerix

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

Coya Therapeutics

CytomX Therapeutics

Genelux

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

HilleVax

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Metagenomi

Ovid Therapeutics

PMV Pharma

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

JMP Securities

HC Wainwright & Co.

Goldman Sachs

Leerink Partners

Piper Sandler

Sagimet Biosciences shares are trading higher after the company announced it was granted an FDA Breakthrough Therapy Designation for Denifanstat for noncirrhotic metabolic dysfunction associated steatohepatitis with moderate to advanced liver fibrosis.

Comments

Sagimet Biosciences

Noticias

Últimas noticias sobre Sagimet Biosciences (NASDAQ:SGMT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL